Assessing of effect of nifedipine on IVF

Assessing the effect of nifedipine on success of embryo placement in infertile women who have been candidates for laboratory treatment

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210227050515N1

Enrollment

Registered

2021-04-30

Start date

2021-04-09

Completion date

Unknown

Last updated

2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: IVF candidates who have a frozen fetus and are referred to Kowsar Infertility Center are divided into two groups and the intervention group is given nifedipine transfer at a dose of 5

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Having a frozen embryo and a candidate for embryo transfer Patients who are candidates for infertility treatment other than in vitro fertilization

Exclusion criteria

Exclusion criteria: Patients who are candidates for infertility treatment other than in vitro fertilization BMI>38 Contraindications to the use of nifedipine and estrogen or progesterone Patients treated with other drugs that interfere with nifedipine

Design outcomes

Primary

Measure	Time frame
Beta HCG test positive rate after IVF. Timepoint: Two weeks after IVF. Method of measurement: Beta HCG test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRana Razavi Dizaji

Oroumia University of Medical Sciences

Razavi.r@umsu.ac.ir+9844322234896

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026